Overview
| Alternate Names: | calcium channel, voltage-dependent, T type, alpha 1Hb subunit; calcium channel, voltage-dependent, alpha 1H subunit; low-voltage-activated calcium channel alpha1 3.2 subunit; low-voltage-activated calcium channel alpha13.2 subunit; voltage dependent t-type calcium channel alpha-1H subunit; voltage-gated calcium channel alpha subunit Cav3.2; voltage-gated calcium channel alpha subunit CavT.2 |
|---|---|
| Alternate Symbols: | CACNA1HB; Cav3.2; EIG6; FLJ90484 |
| PharmGKB Accession Id: | PA380 |
Details
| Cytogenetic Location: | chr16 : p13.3 |
|---|---|
| GP mRNA Boundary†: | chr16 : 1143242 - 1211773 |
| GP Gene Boundary†: | chr16 : 1133242 - 1214773 |
| Strand: | plus |
| Product Name: | calcium channel, voltage-dependent, T type, alpha 1Hb subunit, calcium channel, voltage-dependent, alpha 1H subunit, calcium channel, voltage-dependent, alpha 1H subunit isoform a, calcium channel, voltage-dependent, alpha 1H subunit isoform b, low-voltage-activated calcium channel alpha1 3.2 subunit, low-voltage-activated calcium channel alpha13.2 subunit, voltage dependent t-type calcium channel alpha-1H subunit, voltage-gated calcium channel alpha subunit Cav3.2, voltage-gated calcium channel alpha subunit CavT.2 |
†
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped
onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries
by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for
potential regulatory regions.
Non-Curated Information
A list of non-curated publications that mention this gene along with other genes is available.
PharmGKB Curated Pathways
Curated Information
The following drugs are in curated knowledge about this gene.
| Drug Class | Relationship | Evidence | |
|---|---|---|---|
|
antiarrhythmics, class i and iii |
|
Publications, Pathways |
| Drug | Relationship | Evidence | |
|---|---|---|---|
|
amiodarone |
|
Pathways |
|
|
arsenic trioxide |
|
Pathways |
|
|
cisapride |
|
Pathways |
|
|
disopyramide |
|
Pathways |
|
|
dofetilide |
|
Pathways |
|
|
droperidol |
|
Pathways |
|
|
flecainide |
|
Pathways |
|
|
halofantrine |
|
Pathways |
|
|
haloperidol |
|
Pathways |
|
|
ibutilide |
|
Pathways |
|
|
lidocaine |
|
Pathways |
|
|
mesoridazine |
|
Pathways |
|
|
methadone |
|
Pathways |
|
|
mexiletine |
|
Pathways |
|
|
mibefradil |
|
Publications |
|
|
pentamidine |
|
Pathways |
|
|
pimozide |
|
Pathways |
|
|
procainamide |
|
Pathways |
|
|
propafenone |
|
Pathways |
|
|
quinidine |
|
Pathways |
|
|
sotalol |
|
Pathways |
|
|
sparfloxacin |
|
Pathways |
|
|
thioridazine |
|
Pathways |
|
|
tocainide |
|
Pathways |
Non-Curated Information
A list of non-curated publications that mention this gene along with other drugs is available.
Curated Information
The following diseases are in curated knowledge about this gene.
| Disease | Relationship | Evidence | |
|---|---|---|---|
|
|
Hypertension |
|
Publications |
Downloads
You must sign in before you can download data.
LinkOuts
- Entrez Gene ID:
- 8912
- OMIM Accession:
- 607904
- 611942
- UCSC Genome Browser ID:
- NM_021098
- Ref Seq NM Accession:
- NM_001005407
- NM_021098
- Ref Seq NP Accession:
- AAC67239
- AAD17668
- AAF60160
- AAF60161
- AAF60162
- AAF60163
- AAK61268
- ABC88009
- ABC88010
- ABC88011
- ABC88012
- BAG52041
- CAC42094
- CAD12646
- EAW85683
- EAW85684
- NP_001005407
- NP_066921
- O95180
- Q9NYY6
- Q9NYY7
- Ref Seq NT Accession:
- AC_000059
- AC_000148
- NC_000016
- NT_037887
- NW_001838339
- NW_926018
- UniProtKB Accesssion:
- CAC1H_HUMAN (O95180)
- Ensembl ID:
- ENSG00000196557
- GenAtlas ID:
- CACNA1H
- GeneCard ID:
- CACNA1H
Common Searches
Non-Curated Publications
A list of non-curated publications that mention this gene is available.